Scientific article
English

Short-term quality of life after metastases-directed SBRT : Results of the ESTRO & EORTC OligoCare cohort

Published in

Radiotherapy and oncology, vol. 222, 111645

Publication date

2026-09

First online date

2026-06-18

Abstract

Background and purpose: Metastasis-directed stereotactic body radiotherapy (SBRT), in combination with systemic therapy, is increasingly used in patients with oligometastatic disease (OMD), supported by international guidelines. However, real-world data on health-related quality of life (HRQoL) following SBRT remain limited. This study aimed to describe baseline HRQoL, evaluate changes over time, and identify clinical factors associated with HRQoL and its evolution.

Materials and methods: OligoCare is a pragmatic, prospective cohort study within the E2 -RADIatE registry, including patients with oligometastatic breast, colorectal, non-small cell lung cancer (NSCLC), and prostate cancer treated with SBRT. An optional HRQoL sub-study assesses patient-reported outcomes at baseline and within 6 months post-SBRT. Analyses included descriptive assessment of baseline HRQoL, multivariable regression to identify factors associated with baseline global health status (GHS), and longitudinal evaluation of HRQoL changes. Clinically meaningful changes were defined using a minimal clinically important difference (MCID) of ≥ 10 points.

Results: Of 2,041 patients, 1,033 (50.6%) completed baseline HRQoL questionnaires and 450 (22%) had follow-up data. The median time to follow-up HRQoL assessment was 2.7 months (range 0.5-6.1). Median baseline GHS was 75. Higher baseline GHS was associated with prostate cancer and good performance status (p < 0.0001). At follow-up, mean GHS remained stable (71, SD 19). Among patients with follow-up data, 23% reported worsened HRQoL, 15% improved. No significant associations were found between HRQoL changes and clinical variables.

Conclusion: Early findings support that SBRT for OMD maintains overall HRQoL in most patients, reinforcing its role in multimodal treatment without compromising patient-reported outcomes.

Keywords

  • Oligometastases
  • Patient-reported outcomes
  • Quality of life
  • Stereotactic body radiotherapy

Citation (ISO format)

GRETO, Daniela et al. Short-term quality of life after metastases-directed SBRT : Results of the ESTRO & EORTC OligoCare cohort. In: Radiotherapy and oncology, 2026, vol. 222, p. 111645. doi: 10.1016/j.radonc.2026.111645

Main files (1)

Article (Published version)

Identifiers

Journal ISSN

0167-8140
6views
0downloads

Technical informations

Creation

07/10/2026 13:06:54

First validation

04/11/2026 08:39:51

Update

05/11/2026 08:03:27

Status update

05/11/2026 08:03:27

Last indexation

05/11/2026 08:03:29
All rights reserved by Archive ouverte UNIGE and the University of Geneva
OpenAIRE Indexed & Validated